Nvidia Corp (NASDAQ: NVDA) and Eli Lilly and Co (NYSE: LLY) are launching a lab designed to apply advanced artificial intelligence to drug development. The collaboration will combine Lilly's expertise ...
During the JPM Healthcare Conference, pharma giant Eli Lilly and Co. and NVIDIA announced a partnership to develop a San Francisco-based AI co-innovation lab, including an investment of up to $1 ...
Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...
Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...
Lila Biologics, a startup that spun out of Nobel Laureate David Baker’s lab at the University of Washington, announced a collaboration with pharmaceutical giant Eli Lilly to develop therapies for ...